https://www.iongenomics.bio/p/illumina-taps-dx-veteran-mike-sullivanIon Genomicsen2026-07-09T20:36:22+00:00Illumina Taps Dx Veteran Mike Sullivan as Chief Commercial Officer, Adds Top Lawyerhttps://www.iongenomics.bio/p/nateras-signatera-wins-eu-certificationIon Genomicsen2026-07-09T20:09:08+00:00Natera's Signatera Wins EU Certification for Cancer Recurrence Monitoringhttps://www.iongenomics.bio/p/freenomes-colorectal-cancer-testIon Genomicsen2026-07-09T20:03:13+00:00Freenome's Colorectal Cancer Test Hits All Study Endpoints, Triggers $70M Milestonehttps://www.iongenomics.bio/p/illumina-to-supply-reagents-for-newIon Genomicsen2026-07-08T21:03:29+00:00Newsletter, July 8: Illumina Tech Chosen by Spatial Perturb-Seq Spinouthttps://www.iongenomics.bio/p/illumina-to-supply-ngs-chemistryIon Genomicsen2026-07-08T20:13:47+00:00Illumina to Supply SBS Chemistry for Broad Spinout's Spatial Perturb-Seq Platform